Main Article Content

Abstract

The number of Diabetes Milletus cases in the city of Samarinda is 3.04%. One of the complications of uncontrolled DM can cause nephropathy. DM patients with diabetic nephropathy are described as having chronic albuminuria of 300 mg/24 hours on 2 visits 3 to 6 months. The purpose of this study was to look at the profile and treatment evaluation of patients with Diabetes Mellitus Type 2 complications of nephropathy at a hospital in Samarinda City. The method in this study is non-experimental observational with a descriptive design. With a cross-sectional approach using retrospective data, namely looking at data based on medical records of patients with Diabetes Mellitus Type 2 complications of nephropathy at a hospital in Samarinda City. The results of a study conducted at Samarinda City Hospital with a sample of 94 type 2 DM patients with nephropathy complications who were treated at inpatient installations from January 2021 to March 2022. The percentages were obtained based on gender, namely men (45.74%) ) and women (54.26%). The age range of patients with nephropathy DM is between 18-60 years with the most incidence being 41-60 (57.45%). The treatment profile obtained the greatest results using insulin, namely novorapid insulin (43.43%), lantus (19.74%) ), levemir (13.16%). while the oral drug, sulfonylrea (Gliquidone) 30 mg (13.16%). In this study there were 789 (97.65%) correct doses of 808 drugs and 19 (2.35%) incorrect doses. drug cases that require adjustment of drug dosage because it is influenced by the GFR value.


Keywords: Type 2 Diabetes Mellitus, Dosage Evaluation, Nephropathy Complications, Treatment Profile.

Article Details

References

  1. Almahera, A., & Himayanti, Y. (2023). Sosialisasi Penggunaan Tanaman Obat Herbal Sereh (Cymbopogon citratus) untuk Penyakit Diabetes di Lingkungan Geguntur. Abdinesia: Jurnal Pengabdian Kepada Masyarakat, 3(1), 12-14.
  2. Atika, R., Masruhim, M. A., & Fitriani, V. Y. (2016). Karakteristik Penggunaan Insulin Pada Pasien Diabetes Mellitus Tipe Ii Dengan Gangguan Ginjal Di Instalasi Rawat Inap Rsud a.W. Sjahranie Samarinda. April, 98–108. https://doi.org/10.25026/mpc.v3i1.72
  3. Jodoin, K. (2016). The Renal Drug Handbook: The Ultimate Prescribing Guide for Renal Practitioners, 4th edition. In European Journal of Hospital Pharmacy (Vol. 23, Issue 4). https://doi.org/10.1136/ejhpharm-2016-000883
  4. Jufan, A. Y., Adiyanto, B., & Arifin, A. R. (2020). Manajemen Dan Stabilisasi Pasien Dengan Edema Paru Akut. Jurnal Komplikasi Anestesi, 7(3), 61-73.
  5. Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K. B., & Martín, C. (2020). Pathophysiology of type 2 diabetes mellitus. International journal of molecular sciences, 21(17), 6275.
  6. GINA. (2020). Pedoman Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 Dewasa di Indonesia 2015. (2015). PB PERKENI. Global Initiative for Asthma, 46. www.ginasthma.org.
  7. Gunawan, S., & Rahmawati, R. (2021). Hubungan Usia, Jenis Kelamin dan Hipertensi dengan Kejadian Diabetes Mellitus Tipe 2 di Puskesmas Tugu Kecamatan Cimanggis Kota Depok Tahun 2019. Arsip Kesehatan Masyarakat, 6(1), 15-22.
  8. Iyos, R. N., & Astuti, P. D. (2017). Pengaruh Ekstrak Daun Sirsak (Annona muricata L.) terhadap Penurunan Kadar Glukosa Darah. Jurnal Majority, 6(2), 144-148.
  9. Noordiana. (2015). Analisis Praktik klinik Keperawatan Pada Pasien Congestive Heart Failure FC III-IV Dengan Diabetes Melitus Tipe II Di Rumah ICCU RSUD AB=bdul Wahab Syahranie Samarinda Tahun 2015 Karya Ilmiah Akhir Ners DI dudun Oleh Analisis Praktik Klinik Keperawatanpada.155.https://dspace.umkt.ac.id/bitstream/handle/463.2017/1151/NOORDIANA%2CS.KepKIAN.pdf?sequence=1&isAllowed=y H
  10. International, K. (2020). KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney International, 98(4), S1–S115. https://doi.org/10.1016/j.kint.2020.06.019
  11. Maidah, N. (2019). Proses asuhan gizi terstandar (PAGT) pada pasien PGK (penyakit ginjal kronis) dengan anemia dan hipertensi di Ruang Teratai RSUD Sunan Kalijaga Demak. 31.https://repository.poltekkessmg.ac.id/index.php?p=show_detail&id=23379&keywor
  12. Pambudi, D. B., Safitri, W. A., & Muthoharoh, A. (2021). Potensi Penyakit Penyerta Pada Pengobatan Pasien Diabetes Mellitus Perspektif Terhadap Antidiabetik Oral. Jurnal Ilmiah Kesehatan, 12(2), 601–608. https://doi.org/10.48144/jiks.v12i2.176
  13. Periyasamy, G., Sabeenakumari, M., Parameswaran, S., & Bobby, Z. (2017). Diabetes & Metabolic Syndrome : Clinical Research & Reviews Role of omentin 1 and IL-6 in type 2 diabetes mellitus patients with diabetic nephropathy. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 8–11. https://doi.org/10.1016/j.dsx.2017.08.005
  14. Ramadhani, N. F., Siregar, K. N., Adrian, V., Sari, I. R., & Hikmahrachim, H. G. (2022). Hubungan Aktivitas Fisik dengan Diabetes Melitus Pada Wanita Usia 20-25 di DKI Jakarta (Analisis Data Posbindu PTM 2019). Jurnal Biostatistik, Kependudukan, dan Informatika Kesehatan, 2(2), 72-78.
  15. Riyadi, A., & Muflihatin, S. K. (2021). Hubungan dukungan keluarga dengan manajemen diri pada penderita diabetes mellitus tipe ii di wilayah kerja puskesmas palaran kota samarinda. Borneo Student Research (BSR), 2(2), 1010-1016.
  16. Sanatang, Armayani, H. (2021). Jurnal MediLab Mandala Waluya Vol 5 No 2, Desember 2021 Website : Jurnal Medilab Mandala Waluya, 5(2), 84–91.
  17. Senthilkumar, G. P., Anithalekshmi, M. S., Yasir, M., Parameswaran, S., Packirisamy, R. muthu, & Bobby, Z. (2018). Role of omentin 1 and IL-6 in type 2 diabetes mellitus patients with diabetic nephropathy. Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 12(1), 23–26. https://doi.org/10.1016/j.dsx.2017.08.005
  18. Widiasari, K. R., Wijaya, I. M. K., & Suputra, P. A. (2021). Diabetes Melitus Tipe 2: Faktor Risiko, Diagnosis, Dan Tatalaksana. Ganesha Medicine, 1(2), 114-120.
  19. Wijaya, I. G., Mulyantari, N. K., & Yasa, I. W. (2018). Prevalensi anemia pada diabetes mellitus tipe 2 di rumah sakit Sanglah Denpasar tahun 2014. E-Jurnal Medika, 7(10).